Browse resources

Total results with these characteristics: 1431

Cost-Effectiveness of Japanese Encephalitis Vaccination

This fact sheet summarizes methods and results of cost-effectiveness analyses performed by PATH and its partners to determine the economic implications of introducing JE vaccine programs. The fact sheet is an excerpt from a larger, comprehensive …

Author: PATH

Published: 2009

The Cost-Effectiveness of Rotavirus Vaccination in Armenia

This article, published in Vaccine, evaluates the cost-effectiveness of introducing infant rotavirus vaccination in Armenia in 2012 using Rotarix(R)® using a multiple birth cohort model. The model considered the cost and health implications of …

Author: Jit M, Yuzbashyan R, Sahakyan G, Avagyan T, Mosina L

Published: 2011

Cost-Effectiveness of Routine Immunization to Control Japanese Encephalitis in Shanghai, China

From the Bulletin of the World Health Organization, this article investigates the cost-effectiveness of JE immunization in China and demonstrates that a JE immunization program can be a cost-saving intervention for countries.

Author: Ding D, Kilgore PE, Clemens JD, Liu W, Xu Z

Published: 2003

Costs and Impact of Meningitis Epidemics for the Public Health System in Burkina Faso

Epidemic meningococcal meningitis remains a serious health threat in the African meningitis belt. New meningococcal conjugate vaccines are relatively costly and their efficiency will depend on cost savings realized from no longer having to respond …

Author: Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A

Published: 2011

Costs for Households and Community Perception of Meningitis Epidemics in Burkina Faso

This article, published in Clinical Infectious Diseases, discusses an anthropologic and economic study in Burkina Faso to understand perceptions and behavior relative to meningitis and to determine the cost of illness from bacterial …

Author: Colombini A, Bationo F, Zongo S, et al.

Published: 2009

Costs of Community-Acquired Pediatric Rotavirus Gastroenteritis in 7 European Countries: The REVEAL Study

Investigators found that rotavirus gastroenteritis incurs considerable use of health care resources and results in substantial costs for families of patients and employers. Routine rotavirus vaccination could significantly reduce the related …

Author: Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M

Published: 2007

Costs of Meningitis Sequelae in Children in Dakar, Senegal

In economic evaluations of vaccines protecting against meningitis, treatment and productivity costs due to meningitis sequelae are rarely included in studies from low-income countries, mainly due to lack of data. This study, published in The …

Author: Griffiths UK, Dieye Y, Fleming J, Hajjeh R, Edmond K

Published: 2012

Cotton Rats Previously Immunized With a Chimeric RSV FG Glycoprotein Develop Enhanced Pulmonary Pathology When Infected With RSV, a Phenomenon not Encountered Following Immunization With Vaccinia-RSV Recombinants or RSV

In studies conducted in the 1960s, children previously immunized with a formalin-inactivated respiratory syncytial virus (RSV) vaccine (FI-RSV) developed a greater incidence and severity of pulmonary disease during subsequent natural RSV infection …

Author: Connors M, Collins PL, Firestone CY, et al.

Published: 1992

Coverage, Cost, and Safety Impacts of Primary Container Choice

A single decision on the size and type of a vaccine container can have significant implications on the safety, affordability, and coverage of vaccination in routine and campaign settings. Choosing a single-dose vial instead of a multi-dose container …

Author: International Vaccine Access Center

Published: 2013

Creating a Japanese Encephalitis Surveillance System in Vietnam

This document provides details on PATH's partnership with the National Expanded Program on Immunization in Vietnam to enhance surveillance of JE disease and inform future immunization program planning.

Author: PATH

Published: 2007

Critical Episodes in the Understanding and Control of Epidemic Meningococcal Meningitis

Epidemic meningococcal meningitis continues to be an important worldwide cause of morbidity and mortality, especially in developing countries. Throughout its history, a number of "critical episodes" have occurred that have enhanced understanding of …

Author: Artenstein AW, LaForce FM

Published: 2012

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

This article, published in The New England Journal of Medicine, describes a study to assess preexisting immunity in humans to the new pandemic influenza A(H1N1) virus in order to evaluate seasonal vaccine strategies. Researchers used a …

Author: Hancock K, Veguilla V, Lu X, et al.

Published: 2009

The Cure That Kills

This paper examines the health risks posed by unsafe injections in Africa and outlines some of the programs that are helping reduce these risks.

Author: Practical Patient Care

Published: 2008

Current Concepts in Host-Microbe Interaction Leading to Pneumococcal Pneumonia

This article, published in Current Opinion in Infectious Diseases, reviews new insights into the pathogenesis of pneumococcal disease. The authors discuss new mechanisms by which microbial factors govern the ability of pneumococcus to progress from …

Author: Vernatter J, Pirofski L

Published: 2013

Current HPV Vaccines and Future AIDS Vaccines: Common Challenges and Unprecedented Opportunities

This issue brief discusses how ensuring swift and efficient HPV vaccine introduction in developing countries will not only help address the burden of cervical cancer, but will also provide a valuable opportunity for AIDS vaccine researchers and …

Author: AIDS Vaccine Advocacy Coalition, International AIDS Vaccine Initiative, PATH

Published: 2008

Current Knowledge Regarding the Investigational 13-valent Pneumococcal Conjugate Vaccine

This article, published in Expert Reviews of Vaccines, explains the latest knowledge about the investigational 13-valent pneumococcal conjugate vaccine (PCV-13). It outlines the composition of the vaccine and the trials it has undergone to date …

Author: Dinleyici EC, Yargic ZA

Published: 2009

Current Use and Development of Vaccines for Japanese Encephalitis

This literature review, published in Expert Opinion on Biological Therapy, analyzes use of current JE vaccines and development of alternative vaccine candidates. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to …

Author: Beasley D, Lewthwaite P, Solomon T.

Published: 2008

A Decade of Japanese Encephalitis Surveillance in Sarawak, Malaysia: 1997-2006

From the journal Tropical Medicine and International Health, this summary of surveillance data from Malaysia reveals seasonal peak incidence, age distribution of JE cases, and effect of the JE immunization program on disease incidence.

Author: Wong SC, Ooi MH, Abdullah AR, et al.

Published: 2008

Decade of Vaccines

This supplement to Vaccine features articles on the Decade of Vaccines Global Vaccine Action Plan strategic objectives and the opportunities and challenges associated with its implementation. The 27 articles in the supplement cover a range of …

Author: Alonso PL, de Quadros CA, Lal AA, eds.

Published: 2013

Decade of Vaccines Collaboration

This website provides information about the Decade of Vaccines (DoV) Collaboration, a time-limited consultation process which, as planned, dissolved at the end of 2012. The DoV Collaboration brought together diverse stakeholders to develop a Global …

Author: Decade of Vaccines Collaboration

Published: 2012

Decline in Invasive Pneumococcal Disease After the Introduction of Protein-Polysaccharide Conjugate Vaccine

Published in the New England Journal of Medicine, this study examined population-based data from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prevention to evaluate changes in the burden of invasive disease, defined …

Author: Whitney C, Farley M, Hadler J, et al.

Published: 2003

Decline in Pneumonia Admissions After Routine Childhood Immunization with Pneumococcal Conjugate Vaccine in the USA: A Time-Series Analysis

Published in The Lancet, this article assesses the effect of routine infant immunization with seven-valent pneumococcal conjugate vaccine (PCV7) on rates of all-cause and pneumococcal pneumonia admissions. ABSTRACT ONLY. (Learn how users in …

Author: Grijalva CG, Nuorti JP, Arbogast PG, et al.

Published: 2007

This website provides comprehensive resources on diarrheal disease treatment interventions, including low-osmolarity oral rehydration solution, zinc treatment, and rotavirus vaccines. Traditional interventions such as improved sanitation and …

Author: PATH

Definition and Characterization of Localised Meningitis Epidemics in Burkina Faso: A Longitudinal Retrospective Study

The epidemiology of meningococcal meningitis in the African meningitis belt is characterized by seasonality, localized epidemics, and epidemic waves. To facilitate research and surveillance, the authors of this article, published in BMC Infectious …

Author: Tall H, Hugonnet S, Donnen P, et al.

Published: 2012

Delivering Cervical Cancer Prevention in the Developing World

This report highlights new partnerships and innovations in cervical cancer prevention and treatment. It also provides profiles of success in increasing access to HPV vaccines and treatment from around the world, with country spotlights on Mexico, …

Author: Women Deliver

Published: 2011